Secondary hypertriglyceridemia.
Hipertrigliceridemias secundarias.
Hipertrigliceridemia secundaria
Lipoproteínas de muy baja densidad
Metabolic syndrome
Secondary hypertriglyceridemia
Síndrome metabólico
Very low-density lipoprotein
Journal
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
ISSN: 1578-1879
Titre abrégé: Clin Investig Arterioscler
Pays: Spain
ID NLM: 9208512
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
21
01
2021
accepted:
14
02
2021
entrez:
19
5
2021
pubmed:
20
5
2021
medline:
17
12
2021
Statut:
ppublish
Résumé
Secondary hypertriglyceridemia (HTG) are the most common cause of excess triglyceride rich particles in plasma. Faced with HTG, the first thing to do is rule out if there is a secondary cause since it can interact with genetic susceptibility and further aggravate the HTG. The most common causes are diet with high fat and high glycemic index, obesity, diabetes mellitus, alcohol consumption, renal disease like nephrotic syndrome, hepatic disorders and medications. The most important medications that can influence in HTG are oestrogen, isotretinoin, immunosuppressant therapy, L-asparaginase and with less effect thiazides, beta blockers, atypical antipsychotics and glucocorticoids. Other causes less frequent are endocrinological diseases such as Cushing's syndrome, acromegaly, hypothyroidism; pregnancy, lipodystrophies and autoimmune diseases. Lastly, the identifications and treatment or correction of secondary causes is a corner stone in the treatment of this disease.
Identifiants
pubmed: 34006351
pii: S0214-9168(21)00039-5
doi: 10.1016/j.arteri.2021.02.006
pii:
doi:
Substances chimiques
Triglycerides
0
Types de publication
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
29-36Informations de copyright
Copyright © 2021 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.